67 related articles for article (PubMed ID: 2155588)
1. [Acute myocardial infarction induced by lung cancer chemotherapy with cisplatin and etoposide].
Tsutsumi T; Ozawa Y; Kawakami A; Fujii H; Asamoto H
Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):413-7. PubMed ID: 2155588
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy and side effects of chemotherapy for primary lung cancer with cisplatin and etoposide].
Tsutsumi T; Kawakami A; Ozawa Y; Kawaguchi H; Fujii H; Sawano T; Asamoto H
Gan To Kagaku Ryoho; 1991 May; 18(6):1003-6. PubMed ID: 1851407
[TBL] [Abstract][Full Text] [Related]
3. [High-frequency atrial arrhythmia induced by a cisplatin-etoposide combination].
Petrella V; Alciato P; Cantone PA; Fico D; Gagliardini R
Minerva Med; 1989 Mar; 80(3):305-7. PubMed ID: 2541379
[TBL] [Abstract][Full Text] [Related]
4. Study of paclitaxel, etoposide, and cisplatin chemotherapy combined with twice-daily thoracic radiotherapy for patients with limited-stage small-cell lung cancer: a Radiation Therapy Oncology Group 9609 phase II study.
Ettinger DS; Berkey BA; Abrams RA; Fontanesi J; Machtay M; Duncan PJ; Curran WJ; Movsas B; Byhardt RW;
J Clin Oncol; 2005 Aug; 23(22):4991-8. PubMed ID: 15939930
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase III study. Hellenic Cooperative Oncology Group for Lung Cancer Trials.
Kosmidis PA; Samantas E; Fountzilas G; Pavlidis N; Apostolopoulou F; Skarlos D
Semin Oncol; 1994 Jun; 21(3 Suppl 6):23-30. PubMed ID: 8052870
[TBL] [Abstract][Full Text] [Related]
6. [Phase II study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer].
Sugita T; Matsunaga K; Kobayashi H; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N; Matsumoto H; Okazaki M; Katagami N
Gan To Kagaku Ryoho; 1994 Oct; 21(14):2479-83. PubMed ID: 7944494
[TBL] [Abstract][Full Text] [Related]
7. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
8. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
9. [A comparative randomized phase II study of CDDP, CDDP-carboquone (CQ) and CDDP-etoposide as second-line chemotherapy in small cell lung cancer (SCLC)].
Kobayashi K; Hino M; Kurane S; Yano T; Niitani H; Yamano Y; Hasegawa K; Tuboi E
Gan To Kagaku Ryoho; 1989 Feb; 16(2):207-12. PubMed ID: 2537605
[TBL] [Abstract][Full Text] [Related]
10. Etoposide plus cisplatin followed by thoracic radiation for stage IIIB non-small cell lung cancer: MAOP study 2188.
Lokich J; Auerbach M; Essig L; Fryer J; Fryer D
J Infus Chemother; 1995; 5(2):70-2. PubMed ID: 8521238
[TBL] [Abstract][Full Text] [Related]
11. Second-line chemotherapy in recurrent small cell lung cancer. Results from a crossover schedule after primary treatment with cisplatin and etoposide (EP-regimen) or cyclophosphamide, epirubicin, and vincristin (CEV-regimen).
Sundstrøm S; Bremnes RM; Kaasa S; Aasebø U; Aamdal S;
Lung Cancer; 2005 May; 48(2):251-61. PubMed ID: 15829326
[TBL] [Abstract][Full Text] [Related]
12. Combination chemotherapy for non-small cell lung cancer with doxorubicin and mitomycin or cisplatin and etoposide.
Joss RA; Alberto P; Obrecht JP; Barrelet L; Holdener EE; Siegenthaler P; Goldhirsch A; Mermillod B; Cavalli F
Cancer Treat Rep; 1984 Sep; 68(9):1079-84. PubMed ID: 6090014
[TBL] [Abstract][Full Text] [Related]
13. [A combination chemotherapy of cisplatin and etoposide in small cell lung cancer].
Honda R; Nishiwaki Y; Hino M; Hayashibe A; Yano H; Kitaya T; Matsuyama T
Gan To Kagaku Ryoho; 1986 Oct; 13(10):2965-9. PubMed ID: 3021067
[TBL] [Abstract][Full Text] [Related]
14. Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer.
Chewaskulyong B; Thongprasert S
J Med Assoc Thai; 1998 Jan; 81(1):37-41. PubMed ID: 9470320
[TBL] [Abstract][Full Text] [Related]
15. Cisplatin and etoposide before definitive radiation therapy for inoperable squamous carcinoma, adenocarcinoma, and large cell carcinoma of the lung: a phase I-II study of the Radiation Therapy Oncology Group.
Cox JD; Samson MK; Herskovic AM; Abrams R; Koehler M
Cancer Treat Rep; 1986 Oct; 70(10):1219-20. PubMed ID: 3019546
[TBL] [Abstract][Full Text] [Related]
16. Acute anterior myocardial infarction after chemotherapy for testicular seminoma in a young patient.
Ozben B; Kurt R; Oflaz H; Sezer M; Basaran M; Goren T; Umman S
Clin Appl Thromb Hemost; 2007 Oct; 13(4):439-42. PubMed ID: 17911198
[TBL] [Abstract][Full Text] [Related]
17. Open-label, multicenter, randomized, phase III study comparing oral topotecan/cisplatin versus etoposide/cisplatin as treatment for chemotherapy-naive patients with extensive-disease small-cell lung cancer.
Eckardt JR; von Pawel J; Papai Z; Tomova A; Tzekova V; Crofts TE; Brannon S; Wissel P; Ross G
J Clin Oncol; 2006 May; 24(13):2044-51. PubMed ID: 16648504
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma.
Kakolyris S; Agelidou A; Androulakis N; Tsaroucha E; Kouroussis Ch; Agelidou M; Karvounis N; Veslemes M; Christophylakis Ch; Argyraki A; Geroyianni A; Georgoulias V
Lung Cancer; 2006 Jul; 53(1):59-65. PubMed ID: 16716447
[TBL] [Abstract][Full Text] [Related]
19. Multicyclic dose-intensive chemotherapy supported by autologous blood progenitor cell transplantation for relapsed small cell lung cancer.
Fujimoto N; Ueoka H; Kiura K; Tabata M; Bessho A; Takata I; Sunami K; Hiramatsu Y; Ikeda K; Tanimoto M; Harada M
Anticancer Res; 2003; 23(5b):4229-32. PubMed ID: 14666630
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.
Bunn PA; Kelly K
Semin Oncol; 1996 Dec; 23(6 Suppl 16):11-5. PubMed ID: 9007114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
